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The lymphatic system is crucial for fluid homeo-
stasis, immune responses, and numerous patholog-
ical processes. However, the molecular mechanisms
responsible for establishing the anatomical form
of the lymphatic vascular network remain largely
unknown. Here, we show that chemokine signaling
provides critical guidance cues directing early trunk
lymphatic network assembly and patterning. The
chemokine receptors Cxcr4a and Cxcr4b are
expressed in lymphatic endothelium, whereas che-
mokine ligands Cxcl12a and Cxcl12b are expressed
in adjacent tissues along which the developing
lymphatics align. Loss- and gain-of-function studies
in zebrafish demonstrate that chemokine signaling
orchestrates the stepwise assembly of the trunk
lymphatic network. In addition to providing evidence
for a lymphatic vascular guidance mechanism,
these results also suggest a molecular basis for
the anatomical coalignment of lymphatic and blood
vessels.
INTRODUCTION
The lymphatic system is essential for tissue fluid homeostasis
and immune surveillance and is important in a number of patho-
logical processes, including inflammation, lymphedema, and
tumor metastasis (Alitalo et al., 2005; Oliver and Alitalo, 2005;
Tammela and Alitalo, 2010). Like blood vessels (BVs), lymphatic
vessels (LVs) assemble into a complex but highly stereotypic
and evolutionarily conserved network. The lymphatic network
is anatomically separate and distinct from the circulatory
system, although larger-caliber LVs and BVs (in particular,
arteries) frequently coalign (Gray, 1918; Sabin, 1902, 1909).
The molecular factors regulating emergence of the embryonic
lymphatic vasculature have been studied in a number of different
vertebrates, in particular in mice, resulting in the identification of
key molecules regulating lymphatic specification and differentia-824 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Ition, such as Sox18, Prox1, CoupTFII, VegfC, Vegfr3, and Nrp2
(reviewed in Alitalo et al., 2005; Butler et al., 2009; Oliver and
Alitalo, 2005; Tammela and Alitalo, 2010). However, progress
has been slowed by the difficulty in imaging lymphatics or in
experimentally or genetically manipulating them in most verte-
brate model organisms. The zebrafish has been shown to be
a valuable model for experimental and genetic analysis and
imaging of the blood vascular system (McKinney and Weinstein,
2008), and recent studies have provided evidence that the
zebrafish is also useful for studying lymphatic development
(Bussmann et al., 2010; Del Giacco et al., 2010; Geudens
et al., 2010; Hogan et al., 2009; Ku¨chler et al., 2006; Pedrioli
et al., 2010; Saharinen et al., 2010; Yaniv et al., 2006). The zebra-
fish has a well-defined lymphatic vascular system that shares
many of the morphological, molecular, and functional character-
istics of the LVs found in other vertebrates (Ku¨chler et al., 2006;
Yaniv et al., 2006). A distinct, anatomically conserved system of
lymphatics is present with an overall pattern and morphology
resembling that found in other developing vertebrates. Further-
more, zebrafish lymphatics express known molecular markers
of lymphatic endothelial cell (LEC) fate and require the function
of genes known to be important for lymphangiogenesis in mice
and other species, including the genes noted previously. Zebra-
fish lymphatics also drain and collect subcutaneously injected
dyes, a key functional feature reported for the lymphatics of
other species (Ny et al., 2005; Tilney, 1971). The identification
of a lymphatic system in the zebrafish is an important finding,
given the accessibility of the fish to forward-genetic analysis
and high-resolution in vivo imaging of the vasculature.
As in the blood vascular system, the major vessels of the
lymphatic vascular system have a defined, evolutionarily con-
served anatomical pattern. Recent work has begun to provide
insights into guidance cues directing early patterning of blood
vascular networks, many of which are common to those used
for the patterning of other tissues and organs, in particular
the nervous system (Melani and Weinstein, 2010). However,
the mechanisms responsible for guiding the assembly of the
lymphatic vascular system and establishing its anatomical form
remain largely unknown. A number of zebrafish studies have
begun to explore the mechanisms directing lymphatic develop-
ment and patterning. Imaging and cell lineage tracing studies
documented the assembly of the trunk lymphatic system fromnc.
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that form the ‘‘parachordal line’’ (PC), a structure that serves
as the source of lymphatic endothelium for all trunk lymphatics
(Hogan et al., 2009; Isogai et al., 2003; Ku¨chler et al., 2006; Yaniv
et al., 2006). LECs initially emerge from the PC and migrate
adjacent to trunk arterial intersegmental blood vessels (aISVs),
suggesting that arteries might provide a guidance template
(Bussmann et al., 2010; Geudens et al., 2010; Yaniv et al.,
2006). The involvement of Notch signaling in this arterial align-
ment has been proposed (Geudens et al., 2010), but there is
evidence for both positive and negative functions for Notch in
lymphatic development, and its role remains unclear (see
Discussion). Zebrafish studies have highlighted the functional
requirement for a number of other factors during trunk lymphatic
development. The extracellular matrix-associated protein
collagen and calcium-binding EGF domain-1 (ccbe1) is required
nonautonomously for emergence of lymphatic endothelium from
the primitive veins and for lymphatic assembly, probably acting
as a permissive factor for lymphatic migration (Hogan et al.,
2009). Loss of either claudin-like protein 24 (clp24) or synectin
leads to defects in lymphatic development in both mice and
zebrafish (Geudens et al., 2010; Saharinen et al., 2010). The
microRNA miR-31 has been shown to be required for lymphatic
gene expression, differentiation, and sprouting of human LECs
and lymphatics in developing Xenopus and zebrafish (Pedrioli
et al., 2010). The spleen tyrosine kinase (syk) and related zeta
associated protein-70 (zap-70) are required for both angiogenic
and lymphatigiogenic development in the fish (Christie et al.,
2010).
Although a variety of molecular regulators of lymphatic devel-
opment have now been identified in mice, zebrafish, and other
models, none of these factors has been shown to act as a direct
guidance cue guiding lymphatic patterning, in a manner analo-
gous to the way in which neuronal guidance factors, such as
semaphorin signaling, direct both neural and vascular patterning
(see, e.g., Torres-Va´zquez et al., 2004). Here, we provide
evidence that migration of chemokine receptor Cxcr4a- and
Cxcr4b-positive LEC is guided by chemokine ligands Cxcl12a
(SDF1a) and Cxcl12b (SDF1b) expressed in neighboring tissues
located along the migration pathways taken by these cells.
Our data suggest that chemokine signaling helps direct and
orchestrate the stepwise assembly and patterning of the trunk
lymphatic network.
RESULTS
Stepwise Assembly of the Trunk Lymphatic Network
The emergence of the lymphatic vascular system of the zebrafish
has been described in studies from this and other laboratories
(Bussmann et al., 2010; Geudens et al., 2010; Hogan et al.,
2009; Ku¨chler et al., 2006; Yaniv et al., 2006). We used confocal
and two-photon time-lapse imaging of Tg(fli1a:EGFP)y1 zebra-
fish to examine early zebrafish trunk lymphatic development in
detail (Figure 1; see also Movie S1 available online). Lymphatic
progenitors initially emerge from the PCV as sprouts that grow
dorsally near or along vertical intersegmental boundaries (Isogai
et al., 2003; Figures 1A–1C). As they reach the horizontal
myoseptum (HM), a tissue border dividing the dorsal and ventral
halves of the somites, these sprouts turn laterally into the HM,Devethen branch rostrally and caudally, tracking along the superficial
HM, near the lateral surface of the trunk to populate the PC
(Figures 1D–1K). By 60 hpf, dorsal and ventral sprouts emerge
from the PC at aISVs, tracking closely along the aISVs as they
grow dorsally and ventrally (Figures 1L–1O). The sprouts grow
and extend to form the intersegmental lymphatic vessels (ISLVs).
The dorsal sprouts branch rostrally and caudally as they reach
the dorsal longitudinal anastomotic blood vessels (DLAVs) to
form the dorsal lymphatic lines (DLL), whereas ventral sprouts
branch rostrally and caudally just below the dorsal aorta (DA)
and just above the PCV to form the lymphatic thoracic duct
(TD) (Figures 1P–1R; see also Yaniv et al., 2006). It is important
to reiterate that the ISLVs that branch and grow dorsally and
ventrally from the PC do so only along aISVs, not along venous
intersegmental blood vessels (vISVs) (Figures 1S and 1T; also
noted previously in Yaniv et al., 2006 and more recently in Buss-
mann et al., 2010; Geudens et al., 2010). The complete series of
steps of trunk lymphatic network assembly described previously
are visualized in the two-photon time-lapse imaging sequence
shown in Movie S1. This and previously published (Yaniv et al.,
2006) time-lapse imaging movies show that developing trunk
lymphatics grow and extend as continuous vascular sprouts,
in a similar manner to angiogenic BVs. Expression of Prox1,
a specific marker of lymphatic endothelium (Wigle and Oliver,
1999), is detected in lymphatic progenitors and LEC at each
stage of trunk lymphatic network development beginning from
their appearance as individual cells within the PCV (Figure 1K;
Figure S1).
Chemokine Receptor Cxcr4a Is Expressed in LEC
Chemokine signaling plays a role in cellular guidance and
patterning in various tissues (Bussmann et al., 2011; David
et al., 2002; Doitsidou et al., 2002; Fujita et al., 2011; Ghysen
and Dambly-Chaudie`re, 2007; Haas and Gilmour, 2006; Knaut
et al., 2003; Nair and Schilling, 2008; Siekmann et al., 2009).
Examination of the expression pattern of zebrafish chemokine
receptors suggested that some of them might be involved
in directing the assembly of the trunk lymphatic network (Fig-
ure 2). The chemokine receptor cxcr4a is expressed in devel-
oping lymphatic endothelium. Whole-mount in situ hybridization
(WISH) shows that cxcr4a is initially expressed in the DA and in
the primary intersegmental blood vessel (ISV) sprouts emerging
from it (Figures 2A and 2B). However, cxcr4a expression is
rapidly extinguished in trunk BVs after this stage, and cxcr4a
becomes expressed in developing lymphatics, including the
PC (Figures 2F and 2G) and ISLVs (Figures 2J and 2K).
Higher-magnification WISH images indicate that cxcr4a is
indeed expressed in LECs (Figure 2N). This is confirmed by
high-resolution confocal imaging of vessels in Tg(fli1a:EGFP)y1
animals injected with a recombineered bacterial artificial chro-
mosome (BAC) transgene containing the cxcr4a promoter
upstream of TagRFP-T (Figures 2C–2E, 2H, 2I, 2L, 2M, and
2O; Figures S2A–S2I). TagRFP-T expression (red/yellow) is
detected in endothelial cells (ECs) of the DA and primary ISVs,
where endogenous cxcr4a is initially expressed (Figures S2B–
S2E and S2I), as well as in some ECs in the PCV, where
lymphatic progenitors emerge (Figure S2I). TagRFP-T ex-
pression is also detected in lymphatic progenitors sprouting
from the PCV (arrowheads in Figures 2C–2E; arrowheads inlopmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Inc. 825
Figure 1. Anatomy and Assembly of the Trunk Lymphatic Network in the Developing Zebrafish
(A, D, L, and P) Diagrams illustrating successive steps in trunk lymphatic network assembly at different developmental stages (red, developing lymphatics;
red arrows, their growth direction).
(B, E, M, and Q) Confocal images of the vasculature in Tg(fli1a:EGFP)y1 animals at each stage (yellow boxes, magnified areas shown to the right).
(C, F, N, and O) Magnified views of the boxed portions of the images to the left (green, developing lymphatic vessels, except N).
(G) Cross-sectional diagram illustrating lateral growth of lymphatic progenitors (green) toward the superficial HM (red, arterial BVs; blue, venous BVs; No,
notochord; NT, neural tube; S, somites).
(H) Cross-sectional reconstruction (rotated 90) of confocal stacks used in (E) (arrowheads, vascular spouts extending laterally along the HM).
(I and J) Dorsal view confocal/DIC (I) and confocal only (J) images of a single branching PC sprout (arrowheads) in the superficial HM of a 60 hpf Tg(fli1a:EGFP)y1
larva.
(K) Dorsal view image of a branching PC sprout (arrowheads) in the superficial HM of a 56 hpf larva WISH-stained for prox1.
(R) Color-coded image of (Q) (green, lymphatic vessels; red, arterial BVs; blue, venous BVs).
(S) Confocal image of an aISVs (red/yellow, arrows) with a coaligned ISLV and other developing lymphatics (green, arrowheads) in a 3 dpf Tg(flk:mCherry),
Tg(fli1a:EGFP)y1 double transgenic animal.
(T) Quantification of aISV and vISV (determined by observing vessels using confocal microscopy at 5 dpf) with a coaligned ISLVs. The total number of aISVs
or vISVs counted is shown above each bar.
See also Movie S1 and Figure S1.
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Chemokines and LymphaticsFigures S2B and S2C), in lymphatic sprouts generating the
PC (arrowheads in Figures 2H and 2I), in the PC (arrows in
Figures 2H and 2I; arrows in Figures S2F–S2H), in LEC migrating
dorsally and ventrally from the PC (arrowheads in Figures 2L
and 2M), and in the TD (arrowheads in Figure 2O) with relatively
high frequency (Figure S2I). In addition to cxcr4a, we found that
the related chemokine receptor cxcr4b is also expressed in
the developing lymphatic endothelium (Figures S2J–S2N).
Higher-magnification WISH images revealed cxcr4b expression
in selected cells in the PCV (black arrows in Figures S2J and
S2K), in lymphatic sprouts from the PCV (white arrow in Fig-
ure S2K), in LEC migrating dorsally and ventrally from the PC826 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier I(arrows in Figure S2L), and in the developing TD (arrows in
Figures S2M and S2N).
Cxcl12 Ligands Are Expressed in Tissues Adjacent
to Migrating LEC
Previous work has documented that Cxcl12a and Cxcl12b are
ligands for Cxcr4a and Cxcr4b in the zebrafish (Bussmann
et al., 2011; Chong et al., 2007; Fujita et al., 2011; Nair and
Schilling, 2008; Siekmann et al., 2009). We observe expression
of these ligands adjacent to the paths taken by growing
Cxcr4a/b-positive trunk lymphatics. WISH shows that cxcl12a
is initially expressed in the superficial HM toward whichnc.
Figure 2. Chemokine Receptor Cxcr4a Expression in the Developing Zebrafish Trunk
(A, F, and J) Diagrams indicating Cxcr4a expression domains as red at stages shown below.
(B, G, and K) WISH images corresponding to left panels (arrows, Cxcr4a expression domains; arrowheads, Cxcr4a expression in DA at 24 hpf).
(C–E) Confocal images of a 35 hpf Tg(fli1a:EGFP)y1 embryo (green) injected with a recombineered BAC clone with TagRFP-T driven by the cxcr4a promoter (red).
TagRFP-T is detected in lymphatic progenitors sprouting from the PCV. (C) Merged image. (D) Red channel only. (E) Magnified view in the red box of (C).
(H and I) Confocal images of a 45 hpf Tg(fli1a:EGFP)y1 embryo (green) injected with a recombineered BAC clone with TagRFP-T driven by the cxcr4a promoter
(red). TagRFP-T is detected in sprouting lymphatic progenitors forming the PC. (H) Merged image. (I) Red channel only.
(L and M) Confocal image of a 62 hpf Tg(fli1a:EGFP)y1 embryo (green) injected with a recombineered BAC clone with TagRFP-T driven by the cxcr4a promoter
(red). TagRFP-T is detected in LEC migrating dorsally and ventrally from the PC. (L) Merged image. (M) Red channel only.
(N) High-magnified WISH image showing a cxcr4a-expressing TD sprout extending along the intersegmental boundary (arrows) and between the DA and PCV
(arrowheads) at a 3 dpf animal.
(O) Confocal image of ventral trunk vessels in a 5 dpf Tg(fli1a:EGFP)y1 embryo (green) injected with a recombineered BAC clone with TagRFP-T driven by the
cxcr4a promoter (red). TagRFP-T expression is present in both TD (arrowheads) and DA, but not in the PCV.
See also Figure S2.
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they form the PC (Figures 3A–3D). HM expression of cxcl12a is
extinguished at later stages, when ISLV sprouts begin to exit
the PC, and cxcl12a becomes expressed instead in the PCV,
particularly the dorsal aspect of the PCV immediately below
where the ventral ISLV sprouts grow and branch to form the TD
(Figures 3E–3H). At 3 dpf, trunk expression of cxcl12b is
restricted almost exclusively to aISVs, along which the ISLVs
are migrating, although weak expression is also seen in the DA
immediately above where the ventral ISLVs will branch to form
the TD (Figures 3I and 3J). We verified that cxcl12b expression
is in aISVs but not in vISVs by examining cxcl12b expression in
individual WISH-stained animals in which we had previously
determined the arterial or venous identity (based on blood flow)
of each of the ISVs on both sides of the trunk (Figure 3K; Fig-
ure S3A;Movie S2).We also confirmed that cxcl12b is expressed
in the ECs of the aISVs and DA, but not in adjacent ISLVs, using
high-resolution confocal imaging of vessels in Tg(fli1a:EGFP)y1Deveanimals injected with a recombineered BAC transgene con-
taining the cxcl12b promoter upstream of TagRFP-T (Figures
3L and 3M; Figures S3B–S3G). Together, our expression data
suggest that Cxcr4a/b-positive lymphatic progenitors/cells
might assemble a lymphatic network by migrating toward and/
or along Cxcl12a- or Cxcl12b-expressing tissues.
Chemokine Signaling Is Required for Distinct Steps
of Lymphatic Network Formation
We performed loss-of-function studies using morpholino oligo-
nucleotides (MO) previously shown to efficiently knock down
Cxcr4a, Cxcl12a, and Cxcl12b in the zebrafish (Chong et al.,
2007; Hollway et al., 2007; Knaut et al., 2003) to determine
whether the function of these genes is required for formation of
the trunk lymphatic network (Figures 4A–4K). MO knockdown
of either Cxcr4a (Figures 4D and 4E) or Cxcl12a (splice-blocking
Cxcl12a MO1; Figures 4F and 4G) leads to loss of the PC (white
arrows in Figure 4B) at 55 hpf, and loss of the TD (yellow arrow inlopmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Inc. 827
Figure 3. Chemokine Ligand Cxcl12 Expression in the Developing Zebrafish Trunk
(A–D) Cxcl12a expression in the superficial HM at 24 hpf, as shown in diagram (blue in A), and in WISH lateral view (B), dorsal view (C), and cross-section (D).
(E–H) Cxcl12a expression in the PCV at 3 dpf, as shown in diagram (blue in E), and in WISH lateral view (F) and cross-sections (G and H).
(I and J) Cxcl12b expression in the aISV and DA, as shown in diagram (magenta in I) and in WISH lateral view image (J) at 3 dpf.
(K) Quantification of aISV and vISV (determined by direction of blood flow and by connection to either the DA or PCV as shown in Movie S2) expressing cxcl12b
at 56 hpf and 3 dpf. Numbers of counted aISVs or vISVs at each time point are indicated above the bars.
(L and M) Confocal images of mid-to-ventral trunk vessels in a 3 dpf Tg(fli1a:EGFP)y1 embryo (green) injected with a recombineered BAC clone with TagRFP-T
driven by the cxcl12b promoter (red), showing green and red fluorescence together (L), or red fluorescence only (M). TagRFP-T expression is present in aISVs,
but not in adjacent LVs.
See also Figure S3.
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Chemokines and LymphaticsFigure 4C) at 5 dpf. Embryos injected with a Cxcl12a translation-
blocking MO (Cxcl12a MO2) (Doitsidou et al., 2002) also
displayed lymphatic defects (Figures S4A–S4F) that were indis-
tinguishable from those in embryos injected with Cxcl12a MO1
(Figures 4F and 4G). MO knockdown of Cxcl12b does not cause
any defects in PC formation (Figure 4H) but does cause loss
of the TD at later stages (Figure 4I). All of these results were
confirmed by quantitative analysis (Figures 4J and 4K). Although
a PC is not formed in Cxcl12a and Cxcr4a morphants, vascular
sprouts still emerge from the PCV and grow dorsally to the level
of the HM (purple arrowheads in Figures 4D and 4F; Figure S4B).
We visualized this sproutingmore clearly using aPlcg1morphant
background (Lawson et al., 2003) in which primary DA-derived
ISV sprouts do not form but secondary PCV-derived sprouts
and PC form normally (Figures S4G–S4I). In Cxcl12a/Plcg1,
double morphants PCV-derived sprouts form and grow dorsally
to the level of the HM, but they fail to form PC along the superfi-
cial HM (Figures S4H and S4I). These results suggest that
chemokine signaling is not involved in the PCV-derived sprout-
ing and migration to the level of the HM. We further verified an
endothelial-specific functional requirement for Cxcr4a for trunk
lymphatic development by performing a transgenic rescue828 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Iexperiment (Figures 4L and 4M). Ecdysone-inducible, endothe-
lial-specific overexpression of Cxcr4a using the fli1a promoter
in animals injected with a bidirectional expression construct
(Figure 4L; see Supplemental Experimental Procedures for
further description) rescues the majority of PC formation defects
in Cxcr4a morphants, despite mosaic expression of injected
transgenes (Figure 4M). In addition to defects in ventral ISLV
growth and TD formation, Cxcl12b- or Cxcr4a-deficient animals
also show defects in dorsal ISLV formation (Figures S4J–S4O).
We further analyzed the functions of chemokine signaling for
lymphatic network formation in Cxcr4a mutant, Cxcl12b mutant
(Bussmann et al., 2011), and Cxcl12a medusa mutant (Valentin
et al., 2007) animals (Figures 5A–5E). The cxcl12at30516 mutant
has a G to A base change creating a premature stop at codon
33 removing the last two-thirds of the protein (Valentin et al.,
2007), the cxcl12bmu100 mutant has a frameshift in the cxcl12b
coding sequence after 37 amino acids with a stop codon 23
amino acids later (Bussmann et al., 2011), and the cxcr4aum21
mutant has a frameshift in the cxcr4a coding sequence after 79
amimo acids with a stop codon 32 amino acids later (Bussmann
et al., 2011). As in Cxcl12a, Cxcl12b, or Cxcr4a morphants
(Figures 4E, 4G, 4I, and 4K; Figures S4D and S4F), TD formationnc.
Figure 4. Lymphatic Network Formation Is Disrupted in Chemokine Morphants
(A) Diagram of a zebrafish embryo (a purple box, the region shown in B, D, F, and H; a red box, the region shown in C, E, G, and I).
(B–I) Confocal images of trunk vessels in 55 hpf (B), (D), (F), and (H) or 5 dpf (C), (E), (G), and (I) Tg(fli-EGFP)y1 embryos that were either not injected, or injected with
MOs indicated at left.
(J) Quantification of the PC formation defect in 55 hpf MO-injected embryos (as shown in B, D, F, and H). Values are the mean ± SEM. Numbers of counted
PC segments are indicated above the bars.
(K) Quantification of the TD formation defect in 5 dpf MO-injected embryos (as shown in C, E, G, and I). Values are the mean ± SEM. Numbers of counted TD
segments are indicated above the bars.
(L) Diagram of Cxcr4a rescue constructs for spatiotemporal overexpression of either TagRFP-T + Cxcr4a or TagRFP-T alone (arrows, direction of gene
expression).
(M) Quantification of the PC formation defect in control (column 1) or Cxcr4a morphant animals (columns 2–4), some of which were coinjected with transgenes
for ecdysone-inducible endothelial-specific overexpression of either TagRFP-T (column 3) or Cxcr4a (column 4). Values are the mean ± SEM. Numbers
of counted PC segments are indicated above the bars. White arrows, PC; yellow arrow, TD; red arrows, DA; magenta arrowheads, secondary sprouts migrating
to the level of the HM.
See also Figure S4.
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mutants, or the cxcr4aum21 receptor mutant (Figures 5B–5E).
To further clarify the temporal requirement for Cxcr4 function
during lymphatic network formation, we treated zebrafish
embryos with a known specific Cxcr4 inhibitor, TF10416 (4F-
benzoyl-TN14003), previously used in mice (Tamamura et al.,
2003a, 2003b). Inhibitor treatment from 30 to 55 hpf results in
loss of the PC at 55 hpf (Figures 5F, 5H, and 5J), as well as
loss of the TD at later stages (data not shown), although emer-
gence of lymphatic sprouts from the PCV and migration of
sprouts to the level of the HM are normal (Figure 5H), as shown
previously for Cxcr4a and Cxcl12a morphants (magenta arrow-
heads in Figures 4D and 4F; Figure S4B). Inhibitor treatment
from 3 to 5 dpf, beginning after PC formation is complete, stillDeveresults in loss of the TD at 5 dpf (Figures 5G, 5I, and 5K). These
results suggest that Cxcr4a function is required independently
for both early (PC) and later (TD) stages of trunk lymphatic
network formation and that loss of TD formation following
Cxcr4a knockdown is not merely a secondary consequence of
earlier loss of the PC. This notion is supported by the finding
that PC-positive Cxcr4a MO-injected animals (Figure S5A)
often lack a TD at later stages (Figure S5B). Taken together,
our loss-of-function data show that chemokine signaling is
required for at least two distinct steps of trunk lymphatic network
formation.
Because a recent study reported that netrin1a-mediated
guidance of motoneuron axons into the HM is also required for
PC formation (Lim et al., 2011), we examined whether theselopmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Inc. 829
Figure 5. Deficiency of Chemokine Signaling Results in the Loss of Lymphatic Network
(A–D) Confocal images of trunk vessels in 5 dpf Tg(fli-EGFP)y1wild-type (A), cxcl12at30516/ (B), cxcl12bmu100/ (C), and cxcr4aum21/ (D) homozygous mutant
animals. Red and yellow arrows indicate DA and TD, respectively.
(E) Quantification of TD formation defect in 5 dpf mutant animals. Values are the mean ± SEM. Numbers of counted TD segments are indicated above the bars.
(F–I) Confocal images of trunk vessels in 55 hpf Tg(fli-EGFP)y1 animals treated from 30 to 55 hpf (F) and (H) or 5 dpf Tg(fli-EGFP)y1 animals treated from 3 to 5 dpf
(G) and (I) with either DMSO vehicle (F) and (G) or Cxcr4 inhibitor (H) and (I).
(J) Quantification of the PC formation defect in 55 hpf DMSO vehicle or Cxcr4 inhibitor-treated embryos. Values are the mean ± SEM.
(K) Quantification of the TD formation defect in 5 dpf DMSO vehicle or Cxcr4 inhibitor-treated embryos. Values are the mean ± SEM. In (J) and (K), numbers of
counted PC or TD segments are indicated above the bars.
See also Figure S5.
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network formation by performing combined knockdown using
submaximal MO doses. Indeed, double knockdown of Netrin1a
and Cxcr4a more strongly suppresses early PC formation
(Figure S5C) and later TD formation (Figure S5D) than either
Netrin1a or Cxcr4a knockdown alone. In addition, since Cxcr4b
is also expressed in the developing lymphatic endothelium
(Figures S2J–S2N), we examined whether the Cxcr4a and
Cxcr4b receptors also cooperate during trunk lymphatic network
formation by using combined knockdown with submaximal MO
doses. Again, we found that double knockdown of Cxcr4a and
Cxcr4b more strongly suppresses early PC formation (Fig-
ure S5E) and later TD formation (Figure S5F) than either Cxcr4a
or Cxcr4b knockdown alone. These two sets of data suggest
that a number of partially redundant mechanisms are acting in
concert to direct trunk lymphatic patterning.830 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier IChemokines Direct the Migration and Alignment of LEC
We performed additional gain-of-function studies to examine
whether Cxcl12a and Cxcl12b ligands attract and/or align
the growth of developing lymphatics in vivo. We generated
bidirectional expression constructs in which a chimeric
tebufenozide (TBF)-inducible Gal4-VP16-EcRF0 (GV-EcRF0)
transactivator (Esengil et al., 2007) is placed under the control
of either shh- (for neural floor plate expression) or fli1a
(for endothelial expression)-derived promoter-enhancers and
used to drive UAS-dependent transgene expression. Con-
structs were injected into Tg(fli1a:EGFP)y1 animals for TBF-
inducible ectopic neural floor plate (FP) expression of either
Cxcl12a + TagRFP-T, or TagRFP-T alone (Figures 6A–6H), or
for TBF-inducible ectopic panendothelial expression of either
Cxcl12b + TagRFP-T, or TagRFP-T alone (Figures 6I–6M;
Figure S6).nc.
Figure 6. Ectopic Overexpression of Chemokine Ligands Induces Abnormal Migration of LEC
(A) Diagram of constructs for spatiotemporal overexpression of either TagRFP-T +Cxcl12a (produced cotranslationally using a viral 2A peptide linker) or TagRFP-
T alone (arrows indicate direction of gene expression; see Supplemental Experimental Procedures for details).
(B–G) Confocal images of trunk vessels in 55 hpf Tg(fli-EGFP)y1 embryos injected with constructs as shown in (A) and treated with TBF from 30 hpf (see
Supplemental Experimental Procedures). Yellow boxes in (B) and (E) indicate areas magnified in (C) and (F), respectively. Images in (D) and (G) are 3D
reconstructed cross-sectional views of the same confocal data shown in (B) and (E), respectively (90 horizontal rotation). Dashed lines mark the level of the HM,
where the PC normally forms. Red fluorescence (noted with red arrows) shows neural FP cells expressing TagRFP-T (B)–(D) or TagRFP-T + Cxcl12a (E)–(G).
Developing lymphatics are colorized green in (C), (D), (F), and (G). Green arrows in (F) and (G) point to an ectopic lymphatic sprout extending dorsally beyond the
HM toward nearby TagRFP-T + Cxcl12a-expressing FP cells.
(H) Quantification of ectopic lymphatic sprout migration in segments with TagRFP-T-positive cells in embryos injected with the constructs shown in (A). Values are
the mean ± SEM. The total number of secondary sprouts counted is shown above each bar.
(I) Diagram of constructs for spatiotemporal overexpression of either TagRFP-T + Cxcl12b or TagRFP-T alone (arrows, direction of gene expression; see
Supplemental Experimental Procedures).
(J) Confocal image of ventral trunk vessels in a 5 dpf Tg(fli-EGFP)y1 embryo injected with TagRFP-T + Cxcl12b expression construct (shown in I) and treated with
TBF from 55 hpf (see Supplemental Experimental Procedures).
(K) Same image as in (J) with developing lymphatics colorized green (red arrows, a normal ISLVs adjacent to an aISVs; blue arrows, a mislocalized ISLVs adjacent
to a vISVs).
(L) Quantification of venous ISVs with an immediately adjacent ISLVs in uninjected embryos or embryos injected with constructs shown in (I) with or without
TBF treatment. Values are the mean ± SEM.
(M) Quantification of arterial ISVs with an immediately adjacent ISLVs in uninjected embryos or embryos injected with constructs shown in (I), with or without
TBF treatment. Values are the mean ± SEM. The total number of vISVs (L) or aISVs (M) counted is shown above each bar.
See also Figure S6.
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Figure 7. Proposed Model for Trunk Lymphatic Network Formation
Initial sprouting and dorsal migration of PCV-derived lymphatic progenitors (A) appear to occur independently of chemokine signaling, since sprouts form and
migrate to the level of the HM without chemokine signaling. Cxcl12a guides Cxcr4a/b-expressing PCV-derived sprouting ECs into the superficial HM to form
the PC (B). PC formation is also regulated by netrin1a-guided motoneuron axons in the HM, suggesting cooperative roles of chemokine and nonchemokine
signaling mechanisms during PC formation. Cxcl12b-Cxcr4a/b signaling then guides dorsoventral growth of PC-derived lymphatic sprouts along aISVs but not
vISVs (C). Finally, Cxcl12a and Cxcl12b direct TD formation in the space between the DA and PCV (D). The mechanism directing formation of the DLL adjacent
to the DLAVs blood vessels is at present unknown. Red, developing lymphatics; red arrows, their growth direction.
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all turn laterally at the level of the HM, migrating toward the
Cxcl12a-expressing superficial HM at the lateral surfaces, and
do not grow further dorsally past the HM (Figures 1D–1K). As
expected, lymphatic sprouts adjacent to FP cells expressing
only TagRFP-T do not migrate dorsally past the HM (Figures
6B–6D and 6H). However, lymphatic sprouts near FP cells
expressing both TagRFP-T and Cxcl12a frequently migrate
dorsally past the HM toward the Cxcl12a-expressing cells
(Figures 6E–6H), showing that Cxcl12a can direct migration of
lymphatic progenitors.
As also noted above, ISLVs normally sprout from the PC
adjacent to, and grow along, Cxcl12b-expressing aISVs but
do not grow along Cxcl12b-negative vISVs (Figures 1S and
1T). Injection of a construct for mosaic, TBF-inducible expres-
sion of TagRFP-T alone in EC (Figure 6I) does not cause sig-
nificant misalignment of ISLVs along vISVs following TBF
treatment (Figure 6L). However, mosaic endothelial expression
of TagRFP-T together with Cxcl12b results in frequent misalign-
ment of ISLVs along vISVs (Figures 6J–6L; blue arrows in
Figure 6K), without affecting the normal alignment of ISLVs
along aISVs (red arrows in Figure 6K; Figure 6M). A low level
of lymphatic misalignment along vISVs is seen in Cxcl12b
expression construct-injected animals, even without TBF, but
it is strongly increased by addition of TBF, confirming that
misexpression of Cxcl12b is responsible for the misalignment
phenotype (Figure 6L). Although embryos misexpressing
cxcl12b throughout the vasculature show ectopic alignment
of ISLVs along many vISVs (Figure 6L), the normal alignment
of ISLVs along aISVs is not affected (Figure 6M), as might be
expected, since the endogenous expression of cxcl12b in
aISV has not been perturbed. This results in a somewhat
increased total number of ISLVs in cxcl12b misexpressing
animals. These results show that Cxcl12b can direct the align-
ment of lymphatics along BVs.832 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier IDISCUSSION
Properly directed and coordinated migration of ECs is essential
for formation of stereotypic and evolutionarily conserved
networks of blood and lymphatic vessels during development.
Despite recent advances in our understanding of lymphatic
development (Butler et al., 2009), the molecular mechanisms
regulating lymphatic assembly and patterning remain largely
undetermined. In this study, we provide evidence that chemo-
kine signaling is critical for orchestrating the stepwise assembly
of the trunk lymphatic vascular network (Figure 7). Cxcl12
(SDF1)-Cxcr4 chemokine signaling is required for multiple steps
of trunk lymphatic network assembly. Cxcl12a-Cxcr4 signaling
directs PCV-derived lymphatic progenitors (Figure 7A) to the
superficial HM to form the PC, a transient endothelial cord con-
taining the precursor cells for the developing trunk lymphatic
network (Figure 7B). Cxcl12b-Cxcr4 signaling subsequently
guides the dorsal and ventral growth of lymphatic precursors
sprouting from the PC to form the ISLVs alongside aISVs
(Figure 7C). Later, ventral expression of Cxcl12a in the PCV
and Cxcl12b in the DA appears to mediate the alignment of the
assembling TD between these two BVs (Figure 7D).
As described previously, primitive trunk vasculature in zebra-
fish is formed by DA-derived angiogenic ‘‘primary sprouts’’ and
subsequent PCV-derived ‘‘secondary sprouts’’ (Isogai et al.,
2003). Some of the secondary sprouts have an angiogenic fate,
connecting with the primary sprouts to form vISVs. Other
secondary sprouts adopt a lymphangiogenic fate, migrating
further dorsally to the HM and contributing to the lymphatic PC.
Our results show that Cxcr4 signaling is not required for the initial
specification of Prox1-postive lymphatic progenitors or for their
incorporation into secondary sprouts and dorsal migration to
the level of the HM, because these early events occur normally
in chemokine signaling-deficient animals (Figures 4D, 4F, 5H,
and 7A; Figures S4B, S4H, and S5E). Although initial lymphaticnc.
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such as PC formation along the superficial HM, are disrupted in
chemokine-deficient animals (Figures 4D and 4F; Figures S4B
andS4H). In addition,misexpression ofCxcl12a in theFPattracts
ectopic migration of lymphangiogenic sprouts (Figures 6A–6H).
Interestingly, previous studies have reported similar PC forma-
tion defects in zebrafish deficient in Netrin1a-Unc5b signaling
(Navankasattusas et al., 2008; Wilson et al., 2006). Although
a variety of studies have shown that Netrin acts as an antiangio-
genic or repulsive factor for BV growth (Bouvre´e et al., 2008; Lar-
rive´e et al., 2007; reviewed in Melani and Weinstein, 2010), other
studies have reported an attractive guidance role, notably for ze-
brafish PC formation (Navankasattusas et al., 2008;Wilson et al.,
2006). Like Cxcl12a, Netrin1a is also expressed along the super-
ficial HM (Lauderdale et al., 1997), and deficiency of either Ne-
trin1a, its presumptive receptor Unc5b, or Deleted in colorectal
cancer (Dcc) results in loss of PC formation (Lim et al., 2011; Nav-
ankasattusas et al., 2008; Wilson et al., 2006). However, recent
work has shown that Netrin1a signaling appears to be playing
a nonautonomous role in PC formation and lymphatic patterning
(Lim et al., 2011). The Dcc receptor is expressed in ventrally
migrating motor neuron axons but not in migrating lymphatic
endothelial progenitors, and Netrin1a and Dcc are required for
motor axon positioning along the HM. Loss of these neurons
through genetic or laser ablation results in defects in PC forma-
tion, suggesting that themotor neuronaxonsprovide acue (either
direct or indirect) for PC alignment (Lim et al., 2011). Indeed,
chemokine and netrin signaling appear to be required indepen-
dently forPC formation (Figure 7B) becausenetrin1aMO injection
does not alter the superficial HM expression of Cxcl12a, and
vice-versa (unpublished data), but deficiency of these molecules
together additively inhibits PC formation (Figure S5C).
LEC migration away from the PC is required for the formation
of the trunk lymphatic vascular network, including the ISLVs, TD,
and DLL (Figures 1L, 1P, 1S, 7C, and 7D). As we and others have
reported previously (Bussmann et al., 2010; Geudens et al.,
2010; Hogan et al., 2009; Ku¨chler et al., 2006; Yaniv et al.,
2006), LVs form along preexisting BVs, in particular arterial
BVs. Sprouts emerge from the PC adjacent to, and then migrate
dorsoventrally exclusively along, aISVs, avoiding vISVs (Fig-
ure 1T). The close anatomical association between ISLVs and
aISVs suggests that arterial BVs provide a guidance cue for
growing lymphatics. Indeed, we find that Cxcl12b ligand is ex-
pressed exclusively in aISVs at 3 dpf (Figures 3I–3M; Figures
S3A and S3C–S3E), and Cxcl12b-deficient animals exhibit
failure of both dorsal migration of LECs from the PC (Figures
S4J–S4N) and formation of a ventral TD (Figure 4I) by 5 dpf,
despite normal formation of the PC at earlier stages of develop-
ment (Figure 4H). Furthermore, ectopic panendothelial expres-
sion of Cxcl12b promotes both ectopic migration of LECs and
misalignment of ISLVs along vISVs (Figure 6I–6M; Figure S6),
suggesting that Cxcl12b is the key molecule guiding LEC migra-
tion along aISVs (Figure 7C). A previous study examining the role
of Notch signaling in zebrafish lymphatic development sug-
gested that, in addition to its role in lymphatic emergence, Notch
might also regulate lymphatic vessel pathfinding along arteries
(Geudens et al., 2010). This result probably in large part reflects
the requirement for Notch for artery specification. Notch-
deficient animals form predominately vISVs instead of aISVs,Devedepriving migrating LECs of most of their Cxcl12b-expressing
arterial templates. However, these authors also observed a few
cases in which lymphatic sprouts failed to migrate along or
stalled during migration on ‘‘residual aISVs.’’ Notch signaling
appears to still be active in aISVs during LEC migration from
the PC (Geudens et al., 2010), raising the possibility that Notch
plays a more direct role in lymphatic pathfinding. In this regard,
it would be important to determine whether Cxcl12b expression
is reduced in the residual aISVs found in Notch-deficient animals,
since our results suggest that Cxcl12b is both necessary and
sufficient to direct ISLV-aISV alignment.
Later expression of Cxcl12a and Cxcl12b in the PCV and DA,
respectively (Figure 3E–3J; Figure S3A–S3E), suggests that
these ligands also guide the positioning of the TD. During TD
assembly Cxcl12b expression in the DA is gradually decreasing,
whereas Cxcl12a expression in the PCV is gradually increasing.
This spatial-temporal gradient of chemokine ligand expression
probably ensures that the final destination of ventrally migrating
LECs is the area between DA and PCV (Figure 7D). The role of
Cxcr4a/b-dependent signaling in DLL formation along the
ventral surface of the DLAVs (Isogai et al., 2001) is less clear.
Close apposition between the DLL and the DLAVs suggests
that the DLAVs provide a guidance template for the DLL, but
Cxcl12a and Cxcl12b expression is not detected in the DLAV
at the level of detection of our WISH method.
Together, our results indicate that chemokine signaling plays
a central role in directing trunk lymphatic vascular network
assembly. Cxcr4-expressing LECs migrate to the superficial
HM, along aISVs, and then between the DA and PCV by re-
sponding to Cxcl12 ligands (Figure 7). The blood endothelial
expression of chemokine guidance cues is interesting in light
of the well-documented common anatomical alignment of larger
lymphatics with BVs, particularly arteries, throughout the verte-
brates (Gray, 1918; Sabin, 1902, 1909). This suggests that the
mechanisms described here may have wider implications for
lymphatic patterning and LV growth, not only during embryogen-
esis but also during tumor-derived lymphangiogenesis. Recent
studies have shown that the lymphatic vasculature is an impor-
tant route for the metastatic spread of tumor cells (Achen
et al., 2005; Alitalo et al., 2005; Wang and Oliver, 2010). Tumors
actively induce both lymphangiogenesis and angiogenesis in the
vicinity of tumors by secreting growth factors, such as VEGF-C,
VEGF-D, and VEGF-A. Interestingly, many tumors are also
known to express chemokine ligands and receptors in the tumor
microenvironment, playing important roles in tumor-induced
angiogenesis, tumor growth, and metastasis by autocrine and
paracrine mechanisms (Raman et al., 2007; Somasundaram
and Herlyn, 2009). For example, the CC chemokine receptor 7
(CCR7) in tumor cells responds to its ligand CCL21 in LEC, facil-
itating tumor cell invasion into LEC (Issa et al., 2009; Mu¨ller et al.,
2001; Wiley et al., 2001). The identification of novel lymphatic
guidance cues may therefore also lead to potential new clinical
targets for lymphangiogenesis.EXPERIMENTAL PROCEDURES
Zebrafish
Zebrafish (Danio rerio) embryos were obtained from natural spawning of
laboratory lines. Embryos were raised and fish maintained as previouslylopmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Inc. 833
Developmental Cell
Chemokines and Lymphaticsdescribed (Kimmel et al., 1995; Westerfield, 2000). Zebrafish lines used in the
study are wild-type EK, Tg(fli1a:EGFP)y1 (Lawson and Weinstein, 2002),
cxcr4aum21 (Bussmann et al., 2011), medusa (cxcl12at30516) (Valentin et al.,
2007), and cxcl12bmu100 (Bussmann et al., 2011). Embryos were treated with
1-phenyl-2-thiourea (PTU) to inhibit pigment formation (Westerfield, 2000) to
facilitate imaging and staining for whole-mount in situ hybridization (WISH).
To immobilize embryos for imaging, they were treated with tricaine (Wester-
field, 2000). Our zebrafish work was carried out under an approved animal
protocol (Eunice Kennedy Shriver National Institute of Child Health and Human
Development # 98-039).
Microscopy and Imaging
Embryos were mounted with 9% methyl cellulose for single time-point
imaging. Embryos stained via WISH were imaged with a ProgRes C14 camera
mounted on a Leica MZ12 stereomicroscope. High-magnification images
were captured via a digital camera (The Imaging Source, Charlotte, NC,
USA) mounted on an Olympus BX61WI compound microscope and iMovie
program (Apple Inc., Cupertino, CA, USA). A movie showing blood flow was
obtained from the digital camera (The Imaging Source) mounted on a Leica
MZ FLIII stereomicroscope using iMovie (Apple Inc.). A Leica DC 500 digital
camera mounted on a Zeiss Axioplan 2 compound microscope was used for
obtaining images of sectioned cxcl12a in situ-stained embryos. Confocal
microscopy images were acquired using a FluoView 1000 confocal micro-
scope (Olympus, Center Valley, PA, USA) or a Leica SP5 inverted microscope
(Leica Microsystems, Wetzlar, Germany). The images shown in this paper are
single-view two-dimensional reconstructions of collected z-series stacks.
Time-lapse imaging using two-photon microscopy (Zeiss LSM; Zeiss,
Peabody, MA, USA) was performed as described previously (Kamei and
Weinstein, 2005). Image z-stacks were collected using a Tg(fli1a:EGFP)y1
animal from 1.4 dpf (34 hpf) to 4.6 dpf (100 hpf), collecting images every 15–
20 min. Each z-stack contains 54 sections collected 3 mm apart. Time-lapse
movies were assembled using ImageJ (National Institutes of Health).
BAC Engineering using Homologous Recombination
To investigate the endogenous expression domains of chemokine ligand and
receptor, we modified BAC clones containing genomic elements of Cxcl12b
(ZC106B24) and Cxcr4a (ZH268G8) using homologous recombination (Figures
S2A and S3B). Targeting vectors were made by Multisite Gateway Cloning
(Invitrogen, Grand Island, NY, USA) and In-Fusion PCR Cloning System
(Clontech, Mountain View, CA, USA). Each BAC clone was electroporated
into SW105 (Warming et al., 2005) and selected with chloramphenicol
(12.5 ug/ml). Themodified Cxcr4a BAC clone was further changed by inserting
iTol2 using homologous recombination (iTol2-Cxcr4aBAC; Suster et al., 2009).
See Supplemental Experimental Procedures for targeting vector construction
and homologous recombination.
Plasmid Constructs for In Situ RNA Probes
Because of high degree of identity in coding sequences between cxcl12a and
cxcl12b, 30 UTRs for each gene were amplified from stage-mixed cDNAs
by PCR. A 324 bp PCR product for cxcl12a was generated with cxcl12aF
(50-AAAAAGCCCAACAGCAGCAGG-30) and cxcl12aR (50-ACACGGAGCAA
ACAGGACTCC-30) primers and cloned into pCRII-TOPO vector (Invitrogen).
For cxcl12b, a 548-bp-long PCR product was amplified with cxcl12bF (50-
ATCCTTGCTTTGTGGTCCAG-30) and cxcl12bR (50-TAGCGTTGTGTGACC
AGAGG-30) and cloned into pGEM-T (Promega, Madison, WI, USA). For
cxcr4a, cxcr4aF (50-ACTTGCTGGAGACTGAAGGAG-30) and cxcr4aR (50-
TGCAATGGTCTACATAAGTGC-30 ) primer pairs were used to PCR amplify
a portion of the coding sequence from stage mixed cDNAs. PCR products
were inserted into the pCRII-TOPO vector.
Whole-Mount In Situ Hybridization and Section
RNA probes for cxcl12a, cxcl12b, cxcr4a, cxcr4b, and prox1were labeled with
DIG and a probe for dab2 with fluorescein using a DIG/fluorescein-labeling kit
(Roche, Madison, WI, USA). WISH was carried out as described previously
with some modifications (Hauptmann and Gerster, 1994). In some cases, to
improve penetration of probes and color substrate in later-stage animals, fixed
embryos were cut transversely across the head or trunk with a scalpel in 0.3 M
sucrose solution before WISH procedure. For color staining, BM purple was834 Developmental Cell 22, 824–836, April 17, 2012 ª2012 Elsevier Iused for DIG-labeled probes and INT/BCIP for the fluorescein-labeled probe.
To better characterize the expression domain of cxcl12a, embryos stainedwith
this probe were embedded with JB-4 plastic resin (Polysciences Inc., Warring-
ton, PA, USA) and transverse sections (7–10 mM) were carried out using
a microtome (Leica RM 2165, Leica, Wetzlar, Germany).
Microinjections
For the Cxcr4a rescue experiment, capped Tol2 transposase RNA (35 pg) and
Tol2 plasmids (40 pg) containing a fli1a-derived promoter, EcRF0, and
TagRFP-T or Cxcr4a-encoding sequences (see Figure 4L) were coinjected
with 9 ng Cxcr4a MO into one blastomere of one-cell stage Tg(fli1a:EGFP)y1
embryos. For cxcl12a or cxcl12b ectopic expression experiments, capped
Tol2 transposase RNA (35–50 pg) and Tol2 plasmids (35–50 pg) containing a
tissue-specific promoter, EcRF0, and chemokine ligand-encoding sequences
(see Figures 6A and 6I) were coinjected into the blastomere of one-cell stage
Tg(fli1a:EGFP)y1 embryos. For visualization of Cxcr4a- or Cxcl12b-expressing
cells, 100–150 pg of recombineered BAC DNA (see Figures S2A and S3B) was
injected into the blastomeres of one-cell stage embryos. For the iTol2-Cxcr4a
BAC, 70–80 pg BAC DNA was coinjected with capped Tol2 transposase RNA
(40–50 pg) into the blastomeres of one-cell-stage embryos. Morpholinos
(MOs; Gene Tools, Philomath, OR, USA) were injected into yolk of 1- to 2-
cell-stage embryos. See Supplemental Experimental Procedures for MO
sequences and the injection doses.
Inducible Overexpression Constructs
The Gal4-VP16-Ecdysone (GV-EcRF0):UAS system was utilized for spatiotem-
poral overexpression of chemokine ligands (Esengil et al., 2007). For expression
of cxcl12a in neural floor plate (FP), shh promoter and FP-specific enhancer
(Ar-B) in intron 1 was used (Ertzer et al., 2007). Ar-B (1329 bp) and shh promoter
(2941 bp) fragments were separately amplified from an shh genomic DNA-con-
taining BAC clone (ZC150E22) and connected to each other by overlapping
PCR. The PCR product was cloned into pDONR P2R-P3 vector in an opposite
direction.Forexpressionof cxcl12bandCxcr4a inEC, fli1ep fragment (Covassin
et al., 2009) was cloned into pDONR P2R-P3 vector in an opposite direction.
DNA fragments encoding either TagRFP-T only, or TagRFP-T and chemokine
ligand-coding sequences (containing whole cDNA sequences, including
N-terminal signal peptide-coding sequences), or TagRFP-T andCxcr4a-coding
sequences linkedbyaviral 2Apeptidesequence (Provostetal., 2007;Szymczak
et al., 2004) were amplified by overlapping PCR and cloned into pDONR 221.
The complete inducible constructs were generated using Multisite Gateway
Cloning (Invitrogen) and In-FusionPCRCloningSystem (Clontech). See Supple-
mental Experimental Procedures for inducible constructs.
Treatment of Cxcr4 Inhibitor and Tebufenozide
Cxcr4 antagonist TF10416 (4F-benzoyl-TN14003) (Tamamura et al., 2003a),
a T140 analog, was provided by Dr. Nobutaka Fujii (Kyoto University, Kyoto,
Japan). A stock solution for TF10416 was made by dissolving it in water at
10 mM concentration. To test Cxcr4 function in PC formation, embryos were
incubated from 30 to 55 hpf in E3 embryo buffer (5 mM NaCl, 0.17 mM KCl,
0.33 mM CaCl2, and 0.33 mM MgSO4) containing 25–35 uM Cxcr4 inhibitor.
The role of Cxcr4 in TD formation was tested by treating embryos from 3 to
5 dpf with 0.5–1 uM Cxcr4 inhibitor. Tebufenozide pestanal was purchased
from Fluka, and a stock solutionwasmade by dissolving it in dimethyl sulfoxide
(DMSO; Sigma-Aldrich, St. Louis, MO, USA) at 50 mM concentration. Ecdy-
sone was activated by incubating embryos with E3 embryo buffer containing
10–20 uM Tebufenozide (TBF). Buffer containing either Cxcr4 inhibitor or
TBF was replaced daily. See Supplemental Experimental Procedures for
more detail on TBF treatment.
Statistical Analysis
Data were evaluated with two-tailed unpaired Student’s t test. Each value on
graphs represents the mean ± standard error of the mean (SEM).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
doi:10.1016/j.devcel.2012.01.011.nc.
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